top of page

Inevitability of Voice as a Biomarker

Speaker: Anya Gupta | Company: Sonde Health | Date: 13-14 October 2021 | Full Presentation

Leveraging over 1 million voice samples from 80,000+ individuals, Sonde Health’s proprietary voice-based technology platform detects changes in user health - like mental fitness and respiratory disease - from changes in voice. Using advanced audio signal processing and machine learning, Sonde senses and analyzes subtle vocal changes due to changes in a person’s physiology to provide early health detection and monitoring. Sonde One, its health screening app, helps large organizations to execute a daily population screening regimen that helps reduce the spread of COVID-19, comply with government mandates, and return to work safely. Sonde has also leveraged its SurveyLex platform to enable rapid voice data collection for large clinical research organizations like UCB Pharma,​ Biogen, Massachusetts General Hospital​, Beth Israel Deaconess Medical Center​, Pear Therapeutics​ etc. and thereafter also enable voice-based health-detection models. Anya Gupta, Sonde's VP of Business Development, will describe the process Sonde has used since inception to develop their vocal biomarker platform.

Join TechBlick on an annual pass to join all live online conference or online version of onsite conference access library of on-demand talks (600 talks + PDFs)

portfolio of expert led masterclass year-round platform

And do NOT miss our flagship event in Berlin on 17-18 OCT 2023 focused on Reshaping the Future of Electronics. This event attracts 550-600 participants from all the world and offers a superb ambience and dynamic exhibition floor.

To learn more visit

To see feedback about previous event see


Subscribe for updates

Thank you!

bottom of page